![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, October 17, 2022 5:31:24 PM
There is a new wave of world class IP creation happening from India for the world, not just in traditional software, #saas and tech, but across the board, including #lifesciences. Vyome Therapeutics Inc., Iron Pillar's Fund I portfolio company just released an incredible new paper in #Nature Biomedical Engineering around #antimicrobial resistant bone infection treatment. I am, admittedly, not a biotech expert, but as I always say, we are in the #people business. And this investment was a bet on the team, their domain expertise and deep passion for building a large, global, IP-driven business.
Shiladitya Sengupta, co-founder and Chief Science Officer at Vyome is a #nehruscholar, professor at Harvard Medical School, serial entrepreneur and gem of a human being who is one of the individuals putting #Indian biotech startups on the global map.
While Vyome's 12 year journey has not been an easy one, the #grit, #persistence and #creativity shown by Shiladitya, Venkat Nelabhotla and team is truly admirable. I am truly honored to be a small part of their exciting journey!
Upward and onward!!!
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM